Companies House does not verify the accuracy of the information filed

PHARMARON BIOLOGICS (UK) LTD

Company number 04543737

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
04 Jul 2024	CS01	Confirmation statement made on 20 May 2024 with no updates	View PDF Confirmation statement made on 20 May 2024 with no updates - link opens in a new window - 3 pages (3 pages)
03 Jun 2024	AA	Full accounts made up to 31 December 2023	View PDF Full accounts made up to 31 December 2023 - link opens in a new window - 43 pages (43 pages)
22 Sep 2023	AA	Full accounts made up to 31 December 2022	View PDF Full accounts made up to 31 December 2022 - link opens in a new window - 44 pages (44 pages)
18 Jul 2023	CS01	Confirmation statement made on 20 May 2023 with no updates	View PDF Confirmation statement made on 20 May 2023 with no updates - link opens in a new window - 3 pages (3 pages)
09 Feb 2023	MR01	Registration of charge 045437370001, created on 3 February 2023	View PDF Registration of charge 045437370001, created on 3 February 2023 - link opens in a new window - 13 pages (13 pages)
06 Oct 2022	AA	Full accounts made up to 31 December 2021	View PDF Full accounts made up to 31 December 2021 - link opens in a new window - 43 pages (43 pages)
21 Jul 2022	CS01	Confirmation statement made on 20 May 2022 with no updates	View PDF Confirmation statement made on 20 May 2022 with no updates - link opens in a new window - 3 pages (3 pages)
27 Oct 2021	AP01	Appointment of Mr Stephen Christopher Lewinton as a director on 26 October 2021	View PDF Appointment of Mr Stephen Christopher Lewinton as a director on 26 October 2021 - link opens in a new window - 2 pages (2 pages)
07 Sep 2021	AA	Full accounts made up to 31 December 2020	View PDF Full accounts made up to 31 December 2020 - link opens in a new window - 39 pages (39 pages)
31 Aug 2021	CS01	Confirmation statement made on 20 May 2021 with updates	View PDF Confirmation statement made on 20 May 2021 with updates - link opens in a new window - 4 pages (4 pages)
24 Aug 2021	PSC07	Cessation of Pharmaron Beijing Co Ltd as a person with significant control on 2 August 2021	View PDF Cessation of Pharmaron Beijing Co Ltd as a person with significant control on 2 August 2021 - link opens in a new window - 1 page (1 page)
02 Aug 2021	PSC02	Notification of Pharmaron Beijing Co Ltd as a person with significant control on 30 April 2021	View PDF Notification of Pharmaron Beijing Co Ltd as a person with significant control on 30 April 2021 - link opens in a new window - 1 page (1 page)
14 May 2021	RESOLUTIONS	Resolutions NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2021-05-12	View PDF Resolutions NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2021-05-12 - link opens in a new window - 3 pages (3 pages)
11 May 2021	PSC02	Notification of Pharmaron Biologics (Uk) Holdings Limited as a person with significant control on 30 April 2021	View PDF Notification of Pharmaron Biologics (Uk) Holdings Limited as a person with significant control on 30 April 2021 - link opens in a new window - 2 pages (2 pages)
11 May 2021	PSC07	Cessation of Abbvie Inc. as a person with significant control on 30 April 2021	View PDF Cessation of Abbvie Inc. as a person with significant control on 30 April 2021 - link opens in a new window - 1 page (1 page)
04 May 2021	TM01	Termination of appointment of Crawford David Brown as a director on 30 April 2021	View PDF Termination of appointment of Crawford David Brown as a director on 30 April 2021 - link opens in a new window - 1 page (1 page)
04 May 2021	TM02	Termination of appointment of Patricia Maria Haran as a secretary on 30 April 2021	View PDF Termination of appointment of Patricia Maria Haran as a secretary on 30 April 2021 - link opens in a new window - 1 page (1 page)
04 May 2021	AP03	Appointment of Mr Stephen Lewinton as a secretary on 30 April 2021	View PDF Appointment of Mr Stephen Lewinton as a secretary on 30 April 2021 - link opens in a new window - 2 pages (2 pages)
04 May 2021	AP01	Appointment of Dr Boliang Lou as a director on 30 April 2021	View PDF Appointment of Dr Boliang Lou as a director on 30 April 2021 - link opens in a new window - 2 pages (2 pages)
09 Mar 2021	AA	Full accounts made up to 31 December 2019	View PDF Full accounts made up to 31 December 2019 - link opens in a new window - 39 pages (39 pages)
01 Feb 2021	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 1 page (1 page)
01 Feb 2021	SH19	Statement of capital on 1 February 2021 GBP 1	View PDF Statement of capital on 1 February 2021 GBP 1 - link opens in a new window - 5 pages (5 pages)
01 Feb 2021	CAP-SS	Solvency Statement dated 22/01/21	View PDF Solvency Statement dated 22/01/21 - link opens in a new window - 1 page (1 page)
01 Feb 2021	RESOLUTIONS	Resolutions RES13 ‐ Cancel share prem a/c 25/01/2021 RES06 ‐ Resolution of reduction in issued share capital	View PDF Resolutions RES13 ‐ Cancel share prem a/c 25/01/2021 RES06 ‐ Resolution of reduction in issued share capital - link opens in a new window - 2 pages (2 pages)
26 Jan 2021	PSC02	Notification of Abbvie Inc. as a person with significant control on 8 May 2020	View PDF Notification of Abbvie Inc. as a person with significant control on 8 May 2020 - link opens in a new window - 2 pages (2 pages)

Cookies on Companies House services

PHARMARON BIOLOGICS (UK) LTD

Filter by category